Results 101 to 110 of about 3,657 (192)

Pretomanid vs delamanid in a bedaquiline-linezolid regimen: efficacy in a high-burden tuberculosis mouse model. [PDF]

Antimicrob Agents Chemother
Cummings JE, Woolhiser LK, Guglielmi V, Romano A, Pauly S, Zimmerman M, Kaya F, Walter ND, Robertson GT, Slayden RA.   +9 more
europepmc   +1 more source

ADVANCE-ID bacterial and fungal infections review: antimicrobial resistance research updates. [PDF]

JAC Antimicrob Resist
Manesh A, Mo Y, Wang J, Paterson DL.
europepmc   +1 more source

A Comprehensive Approach to Selection of Adverse Drug Reactions for a Drug with Conditional Marketing Authorisation in the European Union. [PDF]

Adv Ther
Hittel N, Lazarevic N, Martin A, Schorn B, Leporowski A, Zhang V, George V, van Heumen E.   +7 more
europepmc   +1 more source

No phenotypic resistance observed for most group-3 and -4 variants in <i>Mycobacterium tuberculosis</i> genes related to bedaquiline, clofazimine, delamanid, and pretomanid in a Central and West African context. [PDF]

Microbiol Spectr
Massou F, Dewaele K, Gnamy A, Balde R, Mulders W, Mehan CJ, de Jong BC, Affolabi D, Tzfadia O, Rigouts L.   +9 more
europepmc   +1 more source

Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa. [PDF]

Clin Infect Dis
Loveday M, Clarence E, Hlangu S, Singh N, Chotoo S, Brust JCM, Waitt C, Court R, Furin J.   +8 more
europepmc   +1 more source

Incidence and risk factors of adverse drug reactions in multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) regimens containing new drugs: a retrospective study of two national multicenter cohorts. [PDF]

J Thorac Dis
Wang Y, Fu L, Li Z, Liu Y, Li L.
europepmc   +1 more source

Rapid detection of treatment-emergent resistance to bedaquiline and pretomanid in <i>Mycobacterium tuberculosis</i> using TM4::<i>GeNL</i> reporter mycobacteriophages. [PDF]

Microbiol Spectr
Ngema SL, Rajagopalan S, Perumal R, Moodley S, Guzman KJ, Steyn AJC, Jacobs WR, Naidoo K, O'Donnell M, Larsen MH.   +9 more
europepmc   +1 more source

Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain. [PDF]

IJTLD Open
Schiuma M, Piubello A, Saluzzo F, Cattaneo D, Salari F, Covizzi A, Rizzo A, Fama F, Ciubotariu C, Lombardi A, Antinori S, Riva A, Cirillo DM, Gori A, Torre A.   +14 more
europepmc   +1 more source

Implementing shorter all-oral treatment durations for multidrug-resistant tuberculosis in the UK: from concept to application. [PDF]

BMJ Open Respir Res
Chavda A, Gilchrist M, Capstick T, Chen C, Kon OM.   +4 more
europepmc   +1 more source

A scoping review of interventions in childhood tuberculosis prevention and treatment. [PDF]

Public Health Pract (Oxf)
Rahaman MZ, Alam T, Nahar SS, Nahrin R, Bushra IJ, Ahmed S, Banu S, Shahrin L.   +7 more
europepmc   +1 more source